|
2025-04-16 |
2025-04-14 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
1 000
-7.7%
20,74
133 172 USD
|
1 000
-7.7%
|
20,74
|
100 000 USD
|
|
|
2025-04-16 |
2025-04-14 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
1 000
-6.2%
20,19
112 640 USD
|
1 000
-6.2%
|
20,19
|
100 000 USD
|
|
|
2025-03-24 |
2025-03-20 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
15 944
-40.5%
23,11
368 466 USD
|
15 944
-40.5%
|
23,11
|
368 466 USD
|
|
|
2025-03-19 |
2025-03-19 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
8 879
-27.5%
23,10
205 105 USD
|
8 879
-27.5%
|
23,10
|
205 105 USD
|
|
|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
11 464
-32.9%
23,10
264 818 USD
|
11 464
-32.9%
|
23,10
|
264 818 USD
|
|
|
2025-03-14 |
2025-03-12 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
36 372
-61.3%
22,25
809 277 USD
|
36 372
-61.3%
|
22,25
|
809 277 USD
|
|
|
2025-03-14 |
2025-03-12 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
9 051
-25.4%
22,45
203 195 USD
|
9 051
-25.4%
|
22,45
|
203 195 USD
|
|
|
2025-03-12 |
2025-03-10 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
12 409
-13.9%
21,06
261 334 USD
|
12 409
-13.9%
|
21,06
|
261 334 USD
|
|
|
2025-02-12 |
2025-02-10 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
14 000
-14.6%
19,57
273 980 USD
|
14 000
-14.6%
|
19,57
|
273 980 USD
|
|
|
2025-01-15 |
2025-01-13 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
1 677
-1.8%
19,08
31 997 USD
|
1 677
-1.8%
|
19,08
|
31 997 USD
|
|
|
2025-01-15 |
2025-01-13 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
12 323
-12.0%
18,13
223 416 USD
|
12 323
-12.0%
|
18,13
|
223 416 USD
|
|
|
2024-12-18 |
2024-12-16 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
23 017
-19.3%
20,44
470 467 USD
|
23 017
-19.3%
|
20,44
|
470 467 USD
|
|
|
2024-12-10 |
2024-12-09 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
18 860
-45.1%
21,38
403 227 USD
|
18 860
-45.1%
|
21,38
|
403 227 USD
|
|
|
2024-12-10 |
2024-12-06 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
8 969
-28.1%
21,27
190 771 USD
|
8 969
-28.1%
|
21,27
|
190 771 USD
|
|
|
2024-12-05 |
2024-12-05 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
1 123
-4.7%
21,25
23 864 USD
|
1 123
-4.7%
|
21,25
|
23 864 USD
|
|
|
2024-12-05 |
2024-12-04 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
5 024
-18.0%
21,25
106 760 USD
|
5 024
-18.0%
|
21,25
|
106 760 USD
|
|
|
2024-12-05 |
2024-12-03 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
8 969
-28.1%
21,45
192 385 USD
|
8 969
-28.1%
|
21,45
|
192 385 USD
|
|
|
2024-12-02 |
2024-11-29 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
9
-0.0%
22,45
202 USD
|
9
-0.0%
|
22,45
|
202 USD
|
|
|
2024-12-02 |
2024-11-27 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
8 637
-24.6%
22,45
193 901 USD
|
8 637
-24.6%
|
22,45
|
193 901 USD
|
|
|
2024-11-20 |
2024-11-18 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
17 000
-14.2%
21,04
357 680 USD
|
17 000
-14.2%
|
21,04
|
357 680 USD
|
|
|
2024-11-08 |
2024-11-06 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
89 561
-53.0%
23,00
2 059 903 USD
|
89 561
-53.0%
|
23,00
|
2 059 903 USD
|
|
|
2024-10-17 |
2024-10-15 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
17 000
-13.4%
26,87
456 790 USD
|
17 000
-13.4%
|
26,87
|
456 790 USD
|
|
|
2024-09-25 |
2024-09-23 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
17 500
-13.0%
24,99
437 325 USD
|
17 500
-13.0%
|
24,99
|
437 325 USD
|
|
|
2024-09-04 |
2024-09-03 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
1 478
-2.8%
27,13
40 098 USD
|
1 478
-2.8%
|
27,13
|
40 098 USD
|
|
|
2024-09-04 |
2024-09-03 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
59 214
-52.5%
26,09
1 544 893 USD
|
59 214
-52.5%
|
26,09
|
1 544 893 USD
|
|
|
2024-09-04 |
2024-09-03 |
VP
Vente planifiée
|
Moat Ross
CHIEF COMMERCIAL OFFICER
Dirigeant
|
1 160
-5.1%
27,12
31 459 USD
|
1 160
-5.1%
|
27,12
|
31 459 USD
|
|
|
2024-09-04 |
2024-09-03 |
VP
Vente planifiée
|
Moat Ross
CHIEF COMMERCIAL OFFICER
Dirigeant
|
67 346
-74.6%
26,10
1 757 731 USD
|
67 346
-74.6%
|
26,10
|
1 757 731 USD
|
|
|
2024-08-29 |
2024-08-27 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
17 500
-12.7%
26,91
470 925 USD
|
17 500
-12.7%
|
26,91
|
470 925 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
63 049
-50.0%
27,01
1 702 953 USD
|
63 049
-50.0%
|
27,01
|
1 702 953 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
50 000
-28.4%
25,05
1 252 500 USD
|
50 000
-28.4%
|
25,05
|
1 252 500 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
23 075
-11.6%
23,25
536 494 USD
|
23 075
-11.6%
|
23,25
|
536 494 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
100
-0.2%
27,87
2 787 USD
|
100
-0.2%
|
27,87
|
2 787 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
8 446
-15.0%
27,10
228 887 USD
|
8 446
-15.0%
|
27,10
|
228 887 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
7 924
-12.3%
26,36
208 877 USD
|
7 924
-12.3%
|
26,36
|
208 877 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
5 530
-7.9%
25,03
138 416 USD
|
5 530
-7.9%
|
25,03
|
138 416 USD
|
|
|
2024-07-25 |
2024-07-23 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
24 248
-55.7%
24,79
601 108 USD
|
24 248
-55.7%
|
24,79
|
601 108 USD
|
|
|
2024-03-11 |
2024-03-07 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
65 012
-100.0%
21,02
1 366 552 USD
|
65 012
-100.0%
|
21,02
|
1 366 552 USD
|
|
|
2024-03-06 |
2024-03-06 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
5 582
-7.9%
21,00
117 222 USD
|
5 582
-7.9%
|
21,00
|
117 222 USD
|
|
|
2024-03-06 |
2024-03-04 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
3 336
-4.5%
22,00
73 392 USD
|
3 336
-4.5%
|
22,00
|
73 392 USD
|
|
|
2024-03-06 |
2024-03-04 |
VP
Vente planifiée
|
Patel Sanj K
CHAIRMAN & CEO
Administrateur exécutif
|
9 406
-11.3%
21,31
200 442 USD
|
9 406
-11.3%
|
21,31
|
200 442 USD
|
|
|
2024-03-05 |
2024-03-01 |
VP
Vente planifiée
|
Tessari Eben
CHIEF OPERATING OFFICER
Dirigeant
|
1 189
-1.0%
22,03
26 194 USD
|
1 189
-1.0%
|
22,03
|
26 194 USD
|
|
|
2024-03-05 |
2024-03-01 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
18 844
-29.6%
21,77
410 234 USD
|
18 844
-29.6%
|
21,77
|
410 234 USD
|
|
|
2024-03-01 |
2024-03-01 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
9 659
-35.4%
21,45
207 186 USD
|
9 659
-35.4%
|
21,45
|
207 186 USD
|
|
|
2024-03-01 |
2024-02-28 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
5 126
-22.6%
21,79
111 696 USD
|
5 126
-22.6%
|
21,79
|
111 696 USD
|
|
|
2024-02-29 |
2024-02-27 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
10 156
-18.4%
21,03
213 581 USD
|
10 156
-18.4%
|
21,03
|
213 581 USD
|
|
|
2024-01-04 |
2024-01-03 |
VP
Vente planifiée
|
Ragosa Mark
CHIEF FINANCIAL OFFICER
Dirigeant
|
12 000
-43.4%
20,00
240 000 USD
|
12 000
-43.4%
|
20,00
|
240 000 USD
|
|
|
2024-01-04 |
2024-01-02 |
VP
Vente planifiée
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
16 670
-49.5%
19,17
319 564 USD
|
16 670
-49.5%
|
19,17
|
319 564 USD
|
|
|
2023-12-21 |
2023-12-19 |
V
Vente
|
Megna Michael R
CHIEF ACCOUNTING OFFICER
Dirigeant
|
9 316
-35.4%
19,13
178 215 USD
|
9 316
-35.4%
|
19,13
|
178 215 USD
|
|
|
2023-12-11 |
2023-12-07 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
1 501
-3.2%
17,81
26 733 USD
|
1 501
-3.2%
|
17,81
|
26 733 USD
|
|
|
2023-12-11 |
2023-12-07 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
6 702
-12.6%
17,75
118 961 USD
|
6 702
-12.6%
|
17,75
|
118 961 USD
|
|
|
2023-12-11 |
2023-12-07 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
13 017
-19.7%
17,64
229 620 USD
|
13 017
-19.7%
|
17,64
|
229 620 USD
|
|
|
2023-12-11 |
2023-12-07 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
7 380
-10.0%
17,54
129 445 USD
|
7 380
-10.0%
|
17,54
|
129 445 USD
|
|
|
2023-09-06 |
2023-09-05 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
400
-0.9%
17,53
7 012 USD
|
400
-0.9%
|
17,53
|
7 012 USD
|
|
|
2023-07-27 |
2023-07-25 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
7 632
-15.4%
19,69
150 274 USD
|
7 632
-15.4%
|
19,69
|
150 274 USD
|
|
|
2023-07-27 |
2023-07-25 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
16 168
-24.6%
19,25
311 234 USD
|
16 168
-24.6%
|
19,25
|
311 234 USD
|
|
|
2023-07-27 |
2023-07-25 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
5 200
-7.3%
18,01
93 652 USD
|
5 200
-7.3%
|
18,01
|
93 652 USD
|
|
|
2022-12-01 |
2022-11-29 |
V
Vente
|
Quart Barry D
Administrateur non-exécutif
|
21 959
-100.0%
16,15
354 638 USD
|
21 959
-100.0%
|
16,15
|
354 638 USD
|
|
|
2022-11-09 |
2022-11-07 |
VP
Vente planifiée
|
Paolini John F.
CHIEF MEDICAL OFFICER
Dirigeant
|
28 357
-43.8%
15,18
430 459 USD
|
28 357
-43.8%
|
15,18
|
430 459 USD
|
|
|
2021-02-10 |
2021-02-10 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
1 137
-1.3%
23,07
26 231 USD
|
1 137
-1.3%
|
23,07
|
26 231 USD
|
|
|
2021-02-10 |
2021-02-10 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
1 600
-100.0%
23,06
36 896 USD
|
1 600
-100.0%
|
23,06
|
36 896 USD
|
|
|
2021-02-10 |
2021-02-09 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
23 569
-21.8%
23,08
543 973 USD
|
23 569
-21.8%
|
23,08
|
543 973 USD
|
|
|
2021-02-10 |
2021-02-09 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
20 401
-100.0%
23,04
470 039 USD
|
20 401
-100.0%
|
23,04
|
470 039 USD
|
|
|
2021-02-10 |
2021-02-08 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
4 528
-4.0%
23,00
104 144 USD
|
4 528
-4.0%
|
23,00
|
104 144 USD
|
|
|
2021-02-10 |
2021-02-08 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
4 924
-100.0%
23,00
113 252 USD
|
4 924
-100.0%
|
23,00
|
113 252 USD
|
|
|
2021-02-05 |
2021-02-03 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
2 477
-0.8%
22,09
54 717 USD
|
2 477
-0.8%
|
22,09
|
54 717 USD
|
|
|
2020-10-14 |
2020-10-12 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
99 330
-46.9%
21,02
2 087 917 USD
|
99 330
-46.9%
|
21,02
|
2 087 917 USD
|
|
|
2020-10-14 |
2020-10-12 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
150 700
-100.0%
21,02
3 167 714 USD
|
150 700
-100.0%
|
21,02
|
3 167 714 USD
|
|
|
2020-10-14 |
2020-10-09 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
670
-0.3%
21,00
14 070 USD
|
670
-0.3%
|
21,00
|
14 070 USD
|
|
|
2020-10-14 |
2020-10-09 |
VP
Vente planifiée
|
Patel Sanj K
Chairman & CEO
Administrateur exécutif
|
872
-100.0%
21,00
18 312 USD
|
872
-100.0%
|
21,00
|
18 312 USD
|
|
|
2020-07-02 |
2020-07-01 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
2 855
-100.0%
25,84
73 773 USD
|
2 855
-100.0%
|
25,84
|
73 773 USD
|
|
|
2020-07-02 |
2020-07-01 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
26 734
-90.4%
25,32
676 905 USD
|
26 734
-90.4%
|
25,32
|
676 905 USD
|
|
|
2020-06-12 |
2020-06-10 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
13 752
-31.7%
25,07
344 763 USD
|
13 752
-31.7%
|
25,07
|
344 763 USD
|
|
|
2020-04-22 |
2020-04-21 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
955
-3.1%
20,44
19 520 USD
|
955
-3.1%
|
20,44
|
19 520 USD
|
|
|
2020-04-22 |
2020-04-21 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
1 563
-4.9%
19,56
30 572 USD
|
1 563
-4.9%
|
19,56
|
30 572 USD
|
|
|
2020-04-22 |
2020-04-20 |
VP
Vente planifiée
|
Beetham Thomas W.
EVP & Chief Legal Officer
Dirigeant
|
47 423
-59.6%
19,06
903 882 USD
|
47 423
-59.6%
|
19,06
|
903 882 USD
|
|
